Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry.

Klein A, Kaul I, Foeldvari I, Ganser G, Urban A, Horneff G.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1349-56. doi: 10.1002/acr.21697.

PMID:
22649024
[PubMed - indexed for MEDLINE]
2.

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A; Pediatric Rheumatology International Trials Organization.

Arthritis Rheum. 2004 Jul;50(7):2191-201.

PMID:
15248217
[PubMed - indexed for MEDLINE]
Free Article
3.

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.

Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH; Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group.

Arthritis Rheum. 2007 Sep;56(9):3096-106.

PMID:
17763439
[PubMed - indexed for MEDLINE]
Free Article
4.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
[PubMed - indexed for MEDLINE]
5.

The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.

Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN.

J Rheumatol. 2004 Jan;31(1):179-82.

PMID:
14705239
[PubMed - indexed for MEDLINE]
6.

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.

Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA; Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2003 Oct;48(10):2763-8.

PMID:
14558080
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.

Braun J, Kästner P, Flaxenberg P, Währisch J, Hanke P, Demary W, von Hinüber U, Rockwitz K, Heitz W, Pichlmeier U, Guimbal-Schmolck C, Brandt A; MC-MTX.6/RH Study Group.

Arthritis Rheum. 2008 Jan;58(1):73-81. doi: 10.1002/art.23144.

PMID:
18163521
[PubMed - indexed for MEDLINE]
Free Article
8.

Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.

Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V.

Arthritis Rheum. 2005 Feb;52(2):554-62.

PMID:
15693001
[PubMed - indexed for MEDLINE]
Free Article
9.

Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.

Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.

Arthritis Rheum. 2005 Oct;52(10):3030-8.

PMID:
16200612
[PubMed - indexed for MEDLINE]
Free Article
10.

Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis.

Vojinovic J, Damjanov N, D'Urzo C, Furlan A, Susic G, Pasic S, Iagaru N, Stefan M, Dinarello CA.

Arthritis Rheum. 2011 May;63(5):1452-8. doi: 10.1002/art.30238.

PMID:
21538322
[PubMed - indexed for MEDLINE]
Free Article
11.

[Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].

Nesa L, Gobbi C, Alba P, Exeni I, Babini A, Albiero E.

Rev Fac Cien Med Univ Nac Cordoba. 2007;64(4):109-14. Spanish.

PMID:
19928400
[PubMed - indexed for MEDLINE]
12.

Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.

Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.

Arthritis Rheum. 2004 Feb;50(2):364-71.

PMID:
14872477
[PubMed - indexed for MEDLINE]
Free Article
13.

Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group.

Ravelli A, Gerloni V, Corona F, Falcini F, Lepore L, De Sanctis R, Zulian F, Buoncompagni A, Sardella ML, Strano CG, Alessio M, Fantini F, Bardare M, Martini A.

Clin Exp Rheumatol. 1998 Mar-Apr;16(2):181-3.

PMID:
9536397
[PubMed - indexed for MEDLINE]
14.

Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study.

Leiskau C, Thon A, Gappa M, Dressler F.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):302-7. Epub 2012 Apr 13.

PMID:
22409955
[PubMed - indexed for MEDLINE]
15.

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, Schmeling H; German and Austrian Paediatric Rheumatology Collaborative Study Group.

Ann Rheum Dis. 2009 Apr;68(4):519-25. doi: 10.1136/ard.2007.087593. Epub 2008 Apr 15.

PMID:
18413440
[PubMed - indexed for MEDLINE]
16.

Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.

Tuková J, Chládek J, Nemcová D, Chládková J, Dolezalová P.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1047-53.

PMID:
20149329
[PubMed - indexed for MEDLINE]
17.

Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan.

Imagawa T, Takei S, Umebayashi H, Yamaguchi K, Itoh Y, Kawai T, Iwata N, Murata T, Okafuji I, Miyoshi M, Onoe Y, Kawano Y, Kinjo N, Mori M, Mozaffarian N, Kupper H, Santra S, Patel G, Kawai S, Yokota S.

Clin Rheumatol. 2012 Dec;31(12):1713-21. doi: 10.1007/s10067-012-2082-5. Epub 2012 Oct 2.

PMID:
23053683
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.

Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.

Arthritis Rheum. 1999 Oct;42(10):2160-5.

PMID:
10524688
[PubMed - indexed for MEDLINE]
Free Article
19.

Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis.

Lin YT, Tsai MJ, Wang LH, Huang MT, Yang YH, Chiang BL.

J Formos Med Assoc. 2000 Aug;99(8):623-9.

PMID:
10969505
[PubMed - indexed for MEDLINE]
20.

Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.

Schmeling H, Biber D, Heins S, Horneff G.

J Rheumatol. 2005 Sep;32(9):1832-6.

PMID:
16142884
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk